Table 1.
Change in parameters from before the onset of anaemia until the present
| Before onset of anaemia | Onset of anaemia | During anaemia with dabigatran treatment | After improvement of anaemia with dabigatran treatment | |
| Platelets (x1010/l) | 4.1 | 5.9 | 15.2 | 9.5 |
| Reticulocytes (%) | 2.3 | 10.1 | 13.1 | 1.9 |
| IPF (%) | Not measured | 11.9 | 4.3 | 5.5 |
| Schizocytes (%) | 1.8 | 10.9 | 6.6 | 1.0 |
| Fibrinogen (mg/dl) | 79 | 107 | 302 | 181 |
| FDP (μg/ml) | 143.3 | 201.5 | 62.7 | 32.8 |
| D-dimer (μg/ml) | 81.4 | 121.8 | 29.2 | 16.7 |
| TAT (ng/ml) | 68.6 | Not measured | 4.3 | 4.7 |
| PIC (μg/ml) | 8.9 | Not measured | 2.7 | 5.2 |
FDP, fibrin/fibrinogen degradation products; IPF, immature platelet fraction; PIC, plasmin-α2 plasmin inhibitor complex; TAT, thrombin antithrombin complex.